Bill Luby: One year ago, I wrote ZIV Undeservedly Neglected when ZIV was trading about 5,000 shares per day and was not even on the radar of many investors who follow the VIX exchange-traded products space. In the land of inverse VIX-based ETPs, it seemed as if XIV was destined to grab all the headlines and the glory, with ZIV relegated to distant also-ran status. Frankly, I was somewhat concerned that ZIV was an ETP with a great deal of potential that might be shuttered due to neglect long before mainstream investors had an opportunity to discover its charms.
One year later, ZIV is still struggling to find adherents, trading approximately 60,000 shares per day as of late, while its performance has become even more difficult to ignore. Over the past year, ZIV is up 103%; and during that period it had a maximum drawdown of only 19%, as the graphic below illustrates. Of course, one can never cut and paste past performance into the future with any degree of certainty, but the record over the course of the past year points toward the potential of ZIV, neglected or otherwise.
A year ago, I summarized some of my thinking on ZIV as follows:
“I am frankly surprised by the lack of interest investors have shown in ZIV, the VelocityShares Daily Inverse VIX Medium-Term ETN. In a nutshell, ZIV has many of the same benefits of long XIV and/or short VXX positions, with much less risk. Specifically, ZIV benefits from negative roll yield about 65% of the time, with VIX futures data going back to 2004 indicating that the annual benefit due to negative roll averages out at more than 20% per year. With XIV getting all the attention, I wonder if investors are aware that XIV is down and ZIV is up since the two products were launched.
Of course, like XIV, ZIV is exposed to sharp spikes in the VIX, as the chart below reflects. It is worth noting, however, that when the VIX spikes, ZIV can be expected to lose value at about half the rate of losses in XIV. For example, while XIV was falling 75%, ZIV was down 42%. It bears repeating that one of the key features of inverse volatility products is that the potential for large short-term losses is significant, even though the long-term prospects are promising.”
Going forward, ZIV is going to have to make it or break it on its own merits, but for those few who have enjoyed the ride for the past year, it is clear that the potential is enormous – at least under certain market environments.
Related Tickers: iPath S&P 500 VIX Mid-Term Futures ETN (NYSEARCA:VXZ), iPath S&P 500VIX Short Term Futures TM ETN (NYSEARCA:VXX), Proshares VIX ETN (NYSEARCA:UVXY), VelocityShares Daily Inverse VIX ETN (NYSEARCA:XIV), VelocityShares Daily 2x VIX Short Term ETN (NYSEARCA:TVIX), VelocityShares Daily Inverse VIX Medium Term ETN (NYSEARCA:ZIV).
Written By Bill Luby From The VIX and More Disclosure(s): long XIV and ZIV, short VXX at time of writing
Bill is a private investor who also authors the VIX and More (http://vixandmore.blogspot.com/) blog and an investment newsletter from just north of San Francisco. His research and trading interests focus on volatility, market sentiment, technical analysis, and ETFs. Prior to becoming a full-time investor, Bill was a business strategy consultant for two decades and advised clients across a broad range of industries on issues such as strategy formulation, strategy implementation, and metrics. When not trading or blogging, he can often be found running, hiking, and kayaking in Northern California. Bill has a BA from Stanford University and an MBA from Carnegie-Mellon University.